This topic contains a solution. Click here to go to the answer

Author Question: Economist David Ricardo developed the theory of comparative advantage. Indicate whether the ... (Read 109 times)

future617RT

  • Hero Member
  • *****
  • Posts: 543
Economist David Ricardo developed the theory of comparative advantage.
 
  Indicate whether the statement is true or false

Question 2

Which of the following is the most common form of social stratification in the world today?
 
  A) racial segregation
  B) class system
  C) gender-based division
  D) language-based stratification



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

LegendaryAnswers

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

TRUE

Answer to Question 2

B





 

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library